logo blanc horizontal en

Innovation
& pre-filled syringes

Patient safety has & always will be Aguettant's priority. Our teams are focused on the development of a range of health products adapted to the challenges of daily medical practice.

Serving healthcare

professionals

Watch the testimony of Professor William Harrop-Griffiths, Consultant Anaesthetist, Imperial College Healthcare NHS Trust, London, United Kingdom

FR VIDEO INNOVATION frame at 0m18s
What do professional medical organisations say about pre-filled syringes ?
ISMP Institute for Safe Medication Pratices

2015

Recommend that ‘Commercially available, PFS with medications that are already labeled should be used when possible.


To the greatest extent possible, provide adult IV push medications in a Ready To Administer form (to minimize the need for manipulation outside the pharmacy sterile compounding area) (1)

CMS Centers for Medicare & Medicaid Services

2015

Recommend that ‘Whenever possible, medications are dispensed in the most Ready To Administer form available from the manufacturer or, if feasible, in unit doses that have been repackaged by the pharmacy. » (3)

INS Infusion Nurses Society

2016

Recommend that ‘In adults, use IV push medications in an Ready To Administer form (to minimize the need for manipulation outside the pharmacy sterile compounding area).


Do not dilute or reconstitute IV push medications by drawing up the contents into a commercially available, prefilled flush syringe of 0.9% sodium chloride (USP).


Do not withdraw IV push medications from commercially available, cartridge-type syringes into another syringe for administration. (3)

ASHP American Society of Health-System Pharmacists

2018

Recommend that ‘Whenever possible, medications should be available for inpatient use in unit-of-use and Ready-To-Administer packaging without further manipulation by the person administering the medication.


Every effort should be made to reduce situations where the person administering the medication has to withdraw doses from containers, reconstitute powdered drug products, split tablets, or perform other similar manipulations. (2)

Description

Our polypropylene syringes are pre-filled and ready-to-use in sterile packaging.

We strive to design innovative, ready-to-administer solutions to prevent medication errors, especially in emergency situations. (6)

PFS figure

Ready to Administer

at a Glance

Reduction of

medication errors

FLECHE

“A significant number of the potential human factor error steps in preparation of injectable medicines can be completely eliminated when using prefilled prelabelled syringes." (5)


It has been proven that "Medication errors were 17 times less likely when prefilled syringes were used". (6)

FLECHE 2

Reduction of

microbial contamination

FLECHE

"Prefilled syringes have zero contamination as against 6% for manually prepared syringes." (5) (7)

FLECHE 2

Reduced administration

delays

FLECHE

When fast administration is essential, hand-preparing drugs at the bedside can result in delays in treatment. (6)


Ready-to-use pre-filled syringes eliminate preparation time, making them a suitable solution for emergency situations.

FLECHE 2

Reduced risks of injuries

for healthcare professionals

FLECHE

Use of pre-filled syringes eliminates needle-stick and cut injuries when opening glass ampoules. (8)

FLECHE 2

Waste and

waste reduction

FLECHE

Up to 86% of injectable drugs prepared in advance in the operating theater and intensive care are discarded at the end of the day. (9)


Considering all components used in the preparation steps of ampoules (syringe, drug, needle, pad, diluent…etc), pre-filled syringes could reduce your overall plastic use and the amount of waste you send to incinerators.

FLECHE 2

Time saving

for caregivers

FLECHE
The preparation time for the syringes is time-consuming for healthcare staff.

Opting for pre-filled syringes means spending more time with patients.
FLECHE 2
(1) EBA European Board of Anaesthesiology Recommendations for Safe Medication Practice 2015
(2) EAHP Report 2023 GIG Special Interest Group for the investigation of medication errors in intensive care units
(3) SFAR Guidelines for Reducing the environmental impact of general anaesthesia 2022
(4) Preckel B et al. Ten years of the Helsinki Declaration on patient safety in anaesthesiology. Eur J Anaesthesiol 2020; 37:521–610
(5) Adapa RM, Mani V, Murray LJ, Degnan BA, Ercole A, Cadman B, Williams CE, Gupta AK, Wheeler DW. Errors during the preparation of drug infusions: a randomized controlled trial. Br J Anaesth. 2012 Nov;109(5):729-34. doi: 10.1093/bja/aes257. Epub 2012 Jul 31. PMID: 22850220.
(6) Gargiulo DA, Mitchell SJ, Sheridan J, et al. Microbiological contamination of drugs during their administration for anesthesia in the Operating Room. Anesthesiology 2016; 124; 785-794.
(7) European Agency for Safety & Health at Work. https://osha.europa.eu/en/legislation/directives/council-directive-2010-32-eu-prevention-from-sharp-injuries-in-the-hospital-and-healthcare-sector
(8) Barbariol F, Deana C, Lucchese F, Cataldi G, Bassi F, Bove T, Vetrugno L, De Monte A. Evaluation of Drug Wastage in the Operating Rooms and Intensive Care Units of a Regional Health Service. Anesth Analg. 2021 May 1;132(5):1450-1456.
logo vertical en
Contact
Aguettant Canada Inc.
1470 rue Peel, bureau A152
Montréal - Québec - H3A 1T1
Phone : 514-772-6294
Toll-free : 1-833-772-6294
Fax : 1-888-772-0380
injectables@aguettant.ca
Contact us
This site was designed and created by the agency customR in a sustainable way, with technologies to reduce its carbon impact. It produces only 0.2g of CO2 per page viewed and is powered by renewable energy. Carbon calculations were done with websitecarbon.
AGTCA – 01/2025
Last update of the site : 30 January 2025
camera-videochevron-uparrow-right